Each COA documents peptide identity (HPLC and/or mass spectrometry), purity analysis, and the lot reference
OuchiYYoshikawaESekineYFutatsubashiMKannoTOgusuTet al
Blend names such as KLOW and GLOW make products easier to identify, but the component list, total listed strength, available documentation, and research-category fit explain the actual differences
Access delayed
While new research highlights how the use of Ozempic, Wegovy, and similar GLP-1 drugs for weight-loss management has risen dramatically, another study reveals that most users stop taking them within a year, raising questions about whether side effects of the medication have been adequately disclosed
Ethics declarations Competing interests A.C.: AstraZeneca, Eli Lilly, Novo Nordisk, Roche Diagnostics, Sanofi Aventis